These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28193090)
21. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx. Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I; PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356 [TBL] [Abstract][Full Text] [Related]
22. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic. Gupta SB; Murphy G; Koenig E; Adon C; Beyrer C; Celentano D; Khawaja S; Sifakis F; Parry JV; Straus W AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1475-80. PubMed ID: 18160004 [TBL] [Abstract][Full Text] [Related]
23. Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection. Lynch BA; Patel EU; Courtney CR; Nanfack AJ; Bimela J; Wang X; Eid I; Quinn TC; Laeyendecker O; Nyambi PN; Duerr R; Redd AD AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1114-1116. PubMed ID: 28670965 [TBL] [Abstract][Full Text] [Related]
24. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N; AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558 [TBL] [Abstract][Full Text] [Related]
25. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. Bärnighausen T; Wallrauch C; Welte A; McWalter TA; Mbizana N; Viljoen J; Graham N; Tanser F; Puren A; Newell ML PLoS One; 2008; 3(11):e3640. PubMed ID: 18982059 [TBL] [Abstract][Full Text] [Related]
26. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B. Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005 [TBL] [Abstract][Full Text] [Related]
27. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay. Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP; PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218 [TBL] [Abstract][Full Text] [Related]
28. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort. Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C; PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment. Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950 [TBL] [Abstract][Full Text] [Related]
30. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma. Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277 [TBL] [Abstract][Full Text] [Related]
31. [Application of limiting antigen avidity enzyme immunoassay for estimating HIV-1 incidence in men who have sex with men]. Tang XJ; Duan LJ; Liang WL; Cheng S; Dong TL; Xie Z; Liu KM; Yu F; Chen ZH; Mi GD; Liang L; Yan HJ; Chen L; Lin L; Kang DM; Fu XB; Qiu MF; Jiang Z; Xu ZY; Wu Z Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jan; 43(1):72-77. PubMed ID: 35130655 [No Abstract] [Full Text] [Related]
32. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344 [TBL] [Abstract][Full Text] [Related]
33. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa. Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607 [TBL] [Abstract][Full Text] [Related]
34. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. Marinda ET; Hargrove J; Preiser W; Slabbert H; van Zyl G; Levin J; Moulton LH; Welte A; Humphrey J J Acquir Immune Defic Syndr; 2010 Apr; 53(4):496-9. PubMed ID: 20306555 [TBL] [Abstract][Full Text] [Related]
35. Is the bed capture enzyme immunoassay useful for surveillance in concentrated epidemics? The case of female sex workers in Indonesia. Morineau G; Magnani R; Nurhayati A; Bollen L; Mustikawati DE Southeast Asian J Trop Med Public Health; 2011 May; 42(3):634-42. PubMed ID: 21706941 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. Laeyendecker O; Brookmeyer R; Oliver AE; Mullis CE; Eaton KP; Mueller AC; Jacobson LP; Margolick JB; Brown J; Rinaldo CR; Quinn TC; Eshleman SH; AIDS Res Hum Retroviruses; 2012 Aug; 28(8):816-22. PubMed ID: 22014036 [TBL] [Abstract][Full Text] [Related]
37. Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross-sectional survey, South Africa: Assay-based incidence measurement. Woldesenbet S; Kufa-Chakezha T; Lombard C; Manda S; Cheyip M; Ayalew K; Chirombo B; Barron P; Diallo K; Parekh B; Puren A PLoS One; 2021; 16(4):e0249953. PubMed ID: 33852629 [TBL] [Abstract][Full Text] [Related]
38. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH; AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149 [TBL] [Abstract][Full Text] [Related]
39. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort. Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]